Age-Based Risk Estimates for C9orf72RE-related Diseases: Theoretical Developments and Added Value for Genetic Counselling
de Vienne, D.; de Vienne, D. M.
Show abstract
The C9orf72 hexanucleotide repeat expansion is the most common genetic cause of amyotrophic lateral sclerosis (ALS) or frontotemporal dementia (FTD). In genetic counselling, children of mutation carriers are often told that they have a 50% risk of carrying the mutation, but this figure does not take into account the fact that penetrance is age-related, with a unimodal distribution of disease onset around 58 years of age. Using a Bayesian approach, we developed a theory to calculate the probability of carrying the mutation for asymptomatic relatives (children/siblings and grandchildren/niblings) as well as the probability of developing ALS/FDT within a given time frame, based on their age. Using published data on age-related penetrance, we then calculated these probabilities and developed an online simulator that makes it easy to calculate them on a case-by-case basis. The probabilities obtained can be very different from Mendelian values. For example, a 70-year-old asymptomatic child born to a carrier has approximately a 6% risk of being a carrier, which is far from 50%. For grandchildren, taking into account both their age and that of their parents also leads to figures that are much lower than those obtained if only their age were considered. For consultands, the decision to undergo testing is based in part on risk estimates. In this regard, the refined estimates and simulator we propose may prove to be valuable tools for genetic counselling for families affected by ALS/FTD linked to the C9orf72 RE mutation. In addition, the formulas used in this study could also be used to calculate risk estimates for other diseases caused by autosomal dominant mutations with age-dependent penetrance.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The PS4-Likelihood Ratio Calculator: Flexible allocation of evidence weighting for case-control data in variant classification 90%
- How do clinician and parent reported data differ? An analysis of similarity and difference in the datasets from a cross-syndrome genetics cohort study(GenROC) 89%
- Analysis of 200,000 exome-sequenced UK Biobank subjects illustrates the contribution of rare genetic variants to hyperlipidaemia 89%
Similar papers in this journal
- Towards development of a statistical framework to evaluate myotonic dystrophy type 1 mRNA biomarkers in the context of a clinical trial 93%
- Time-to-event estimation of birth year prevalence trends: a method to enable investigating the etiology of childhood disorders including autism 92%
- Future prevalence of type 2 diabetes – a comparative analysis of chronic disease projection methods 92%
Similar papers in this journal
- Genetic Architecture of Complex Traits and Disease Risk Predictors 93%
- Causal attribution of smoking and BMI to the landscape of disease incidence in UK Biobank 92%
- Sibling Variation in Phenotype and Genotype: Polygenic Trait Distributions and DNA Recombination Mapping with UK Biobank and IVF Family Data 92%
Similar papers in this journal
- GenOtoScope: Towards automating ACMG classification of variants associated with congenital hearing loss 91%
- A time-series analysis of blood-based biomarkers within a 25-year longitudinal dolphin cohort. 91%
- Inferring age-specific differences in susceptibility to and infectiousness upon SARS-CoV-2 infection based on Belgian social contact data 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.